Latest filing published 08 Nov 2024 for Charles River Laboratories International, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William D. Barbo (chief executive) discloses dealings in Charles River Laboratories International, Inc. to SEC (Form 4). The record holds 24 filings, for trades running from 28 May 2021 to 7 November 2024.
Every open-market trade on record is a sale: 6 sales worth €2.7M. Outside the open market, there are 9 share grants and 1 option exercise. 2024 to date brings no purchases and 1 sale.
The record was last updated on 8 November 2024 with a transaction in Charles River Laboratories International, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations